Last Price$60.00.0%
Market Cap$2,336.7M
$8,000.0
N/A
($76.3M)
+53.2% YoY
($284.7M)
Net Debt to FCF - 4.3x
($65.9M)
(824,137.5% margin)
LBPH Income Statement
LBPH Income Statement Overview
Annual
Quarterly
LTM
Dec'20
Dec'21
Dec'22
Dec'23
LBPH Income statement key metrics
Annual
Quarterly
LTM
LBPH Balance Sheet
LBPH Balance Sheet Overview
Annual
Quarterly
LTM
Dec'20
Dec'21
Dec'22
Dec'23
Assets
Liabilities
Total assets
$50.7M
Current assets ($50.2M, 99.1% of total)
$48.5M (95.7%)
$0.0 (0.0%)
Other current assets
$1,723.0K (3.4%)
Non-current assets ($476.0K, 0.9% of total)
$0.0 (0.0%)
$476.0K (0.9%)
$0.0 (0.0%)
Other non-current assets
$0.0 (0.0%)
Financial position
($48.0M)
Cash & Short-term
Investments
Total Debt
LBPH Balance Sheet Metrics
Annual
Quarterly
LTM
LBPH Cash Flow Statement
LBPH Cash Flow Statement Overview
Annual
Quarterly
LTM
Dec'20
Dec'21
Dec'22
Dec'23
$3,556.0K Net Change in Cash
LBPH Cash Flow Statement key metrics
Annual
Quarterly
LTM
Operating Cash Flow (OCF)
($50.9M) +33.6% YoY
Capital Expenditure (CAPEX)
$0.0 N/A YoY
Free Cash Flow (FCF)
($50.9M) +33.6% YoY
LBPH Financials
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|
% growth | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% |
| Cost of Goods Sold (COGS) | 0.0 | 0.0 | 0.0 | 0.0 |
% margin | 0.0 0.0% | (0.0) 0.0% | (0.0) 0.0% | (0.0) 0.0% |
| Operating Expenses | 14.4 | 27.8 | 44.8 | 56.8 |
| Research & Development Expenses (R&D) | 4.6 | 19.8 | 34.6 | 43.8 |
| Selling, General & Administrative Expenses (SG&A) | 9.8 | 8.1 | 10.2 | 13.0 |
% margin | (14.4) 0.0% | (27.8) 0.0% | (44.8) 0.0% | (56.8) 0.0% |
| Interest Income | 0.0 | 0.1 | 0.8 | 2.4 |
| Interest Expense | 0.0 | 0.0 | 0.8 | 0.0 |
| Pre-tax Income | (14.4) | (27.8) | (43.9) | (54.4) |
% effective tax rate | (0.0) 0.1% | (0.1) 0.2% | (0.9) 1.9% | 0.0 0.0% |
% margin | (14.4) 0.0% | (27.7) 0.0% | (43.1) 0.0% | (54.4) 0.0% |
| EPS | (0.82) | (1.62) | (2.51) | (2.39) |
| Diluted EPS | (0.82) | (1.62) | (2.51) | (2.39) |
% margin | (14.4) 0.0% | (27.8) 0.0% | (44.8) 0.0% | (56.8) 0.0% |
FAQ
What is the Longboard Pharmaceuticals, Inc. (LBPH) revenue?
The Longboard Pharmaceuticals, Inc. (LBPH) revenue is $0.0, reflecting a year-over-year (YoY) growth of N/A.
What is the Longboard Pharmaceuticals, Inc. (LBPH) Net Income?
The Longboard Pharmaceuticals, Inc. (LBPH) Net Income is ($54.4M), showcasing a YoY growth of +26.3% YoY.
What is Longboard Pharmaceuticals, Inc. (LBPH) net debt?
What is the Longboard Pharmaceuticals, Inc. (LBPH) Free Cash Flow (FCF)?
The Longboard Pharmaceuticals, Inc. (LBPH) Free Cash Flow (FCF) stands at ($50.9M), accounting for a N/A margin.